Literature DB >> 10519438

Postpartum bone mineral density following antenatal dexamethasone therapy.

O Ogueh1, G Khastgir, J W Studd, H King, M R Johnson.   

Abstract

The aim of this study was to determine whether the changes in bone metabolism, which we have demonstrated previously with antenatal dexamethasone therapy, are associated with a lower bone mineral density. We assessed bone mineral density in the proximal femur and lumbar spine using dual photon X-ray absorptiometry after delivery in 15 women who received dexamethasone therapy for fetal lung maturation, and in 30 women who did not have dexamethasone therapy in pregnancy. The absolute bone mineral density, T scores and Z scores at the proximal femur and lumbar spine were similar, and the median values of T and Z scores were positive in both groups. We conclude that antenatal dexamethasone therapy has no long term effect on bone mineral density.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519438     DOI: 10.1111/j.1471-0528.1999.tb08120.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  2 in total

1.  Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroids.

Authors:  Mary A Carroll; Alex C Vidaeff; Lisa Mele; Ronald J Wapner; Brian Mercer; Alan M Peaceman; Yoram Sorokin; Donald J Dudley; Catherine Y Spong; Kenneth J Leveno; Margaret Harper; Steve N Caritis; Menachem Miodovnik; John M Thorp; Atef Moawad; Mary J O'Sullivan; Marshall W Carpenter; Dwight J Rouse; Baha Sibai
Journal:  Obstet Gynecol       Date:  2008-06       Impact factor: 7.661

2.  Bone metabolism in fetuses of pregnant women exposed to single and multiple courses of corticosteroids.

Authors:  Linda Fonseca; Susan M Ramin; Lisa Mele; Ronald J Wapner; Francee Johnson; Alan M Peaceman; Yoram Sorokin; Donald J Dudley; Catherine Y Spong; Kenneth J Leveno; Steve N Caritis; Menachem Miodovnik; Brian Mercer; John M Thorp; Mary Jo O'Sullivan; Marshall W Carpenter; Dwight J Rouse; Baha Sibai
Journal:  Obstet Gynecol       Date:  2009-07       Impact factor: 7.661

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.